Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis

  • Amer Jaber1, 4Email author,
  • Gian B Bozzato^1,
  • Lionel Vedrine2,
  • Wes A Prais2,
  • Julie Berube2 and
  • Philippe E Laurent3
^Deceased
BMC Neurology20088:38

DOI: 10.1186/1471-2377-8-38

Received: 27 March 2008

Accepted: 10 October 2008

Published: 10 October 2008

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Mar 2008 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Apr 2008 Reviewed Reviewer Report - Daniel D. Mikol
6 May 2008 Reviewed Reviewer Report - Mark Freedman
16 Jun 2008 Author responded Author comments - Amer Jaber
Resubmission - Version 3
16 Jun 2008 Submitted Manuscript version 3
17 Jul 2008 Reviewed Reviewer Report - Mark Freedman
10 Aug 2008 Author responded Author comments - Amer Jaber
Resubmission - Version 4
10 Aug 2008 Submitted Manuscript version 4
21 Aug 2008 Author responded Author comments - Amer Jaber
Resubmission - Version 5
21 Aug 2008 Submitted Manuscript version 5
2 Oct 2008 Author responded Author comments - Amer Jaber
Resubmission - Version 6
2 Oct 2008 Submitted Manuscript version 6
Publishing
10 Oct 2008 Editorially accepted
10 Oct 2008 Article published 10.1186/1471-2377-8-38

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Merck Serono International S.A
(2)
BD Medical – Pharmaceutical Systems
(3)
BD Medical – Pharmaceutical Systems
(4)
UCB Pharma SA, Chemin du Foriest

Advertisement